Factor IX Activity

Factor IX is a protein produced by the liver and helps with blood clotting. This test was used to screen the activity of factor IX to diagnose Hemophilia B (Deficiency of factor IX)
Test Code: 748
₹ 4,000.00

Factor IX Activity:

Why Factor IX Activity Test?


Hemophilia is a disease where blood does not clot properly. Each time a person bleeds, it triggers a series of reactions known as the coagulation cascade to form clots to stop bleeding. Clotting factor tests are also called as ‘factor assays tests’ or “screening for factor assays” are required to diagnose bleeding disorders. Other screening tests for detecting clotting disorders include CBC (looks for any abnormalities in RBCs, WBCs and mainly the abnormalities seen platelets and in the platelet count), activated partial thromboplastin time (APTT): This tests looks for how long it takes for blood to clot and hence if any of these clotting factors are too low then clotting will take longer time, Prothrombin time (PT): It measures the time taken to form a clot as it measures the clotting ability of factors I, II, V, VII and X and thus if any of these clotting factors are too low then clotting will take longer time, Fibrinogen test is also known as Factor 1 Test: This test is performed when the patient has abnormal PT or APTT test results, clotting factor tests also known as Factor Assays: This test assay helps to screen for diagnosis of bleeding disorder as in case of hemophilia and also to assess its severity (i.e this test helps inaccurate classification of hemophilia B) etc. Patients before this test must not have received medications such as Coumadin, warfarin, blood thinners, heparin therapy like LMWH etc, since it will interfere with the true test results. Other factors which may influence the test results are vitamin K deficiency and conditions like liver diseases, lupus anticoagulants etc. Factor IX also called plasma thromboplastin component, anti-hemophilic factor B, chromogenic factor IX etc. Factor IX is a vitamin K dependent serine protease synthesized in the liver, which involves in the intrinsic coagulation pathway. Congenital Factor IX deficiency is an inherited X-linked bleeding disorder also called as hemophilia B. It is characterized by deep tissue bleeding, excessive bleeding with trauma, ecchymoses, hemarthoses etc. Factor IX activity test: This test is known as Factor IX deficiency test, Christmas factor test, coagulation Factor IX activity assay, Intrinsic protein factor test etc. This test is useful for diagnosing haemophilia B (Christmas disease), assessing the impact of liver diseases on hemostasis, investigating a prolonged partial thromboplastin time etc. This is also used for muscle haemorrhage, hematomas, menorrhagia, epistaxis, monitoring coagulation factor replacement therapy etc. Hence positive test results for Factor IX deficiency is also called Christmas disease, maybe predisposed due to either congenital causes like haemophilia B/ factor IX hemophilia or due to acquired causes such as vitamin K deficiency, warfarin overdose, liver diseases, consumptive coagulopathy, DIC etc. Other additional tests include stool test and urinalysis, genetic testing etc. 

 General Instructions:

Sample Requirement: Specimen - Blood sample collected from the vein. Test Preparation: None.

NOTE - Sample for specimen collections may vary based on the patient’s condition/cases according to the patient’s presenting complaints/signs or symptoms:

SPECIMEN REQUIREMENT (Special or Rare Cases) - As instructed and guided by Physician / Clinician / Pathologist / as per Laboratory’s requirements, according to procedures and protocols.

This Multi-Specialty Clinical Referral Laboratory RTDIAGNOSTICS provides precise and accurate tests with an extensive range of testing services to the medical centres to help in the diagnosis and identification of pathology in the test specimens for infectious diseases and also to evaluate the function of organ systems of the patient. It prevents further complications and helps to stabilize and restore health to near normalcy at the earliest without delay.